Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis

被引:58
作者
Radovits, B. J. [1 ]
Fransen, J. [1 ]
van Riel, P. L. C. M. [1 ]
Laan, R. F. J. M. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.1136/ard.2007.079913
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objectives: To investigate the influence of age and gender on the components of the 28-joint Disease Activity Score (DAS28) in patients with rheumatoid arthritis (RA), and to clarify whether a high DAS28 can be equally interpreted in all age groups, independent of gender. Methods: A prospective cohort of 553 patients with RA was studied for approximately 20 years after diagnosis. The single measures of disease activity and the share of different components of the DAS28 (eg, erythrocyte sedimentation rate; ESR) were analysed and compared between three age groups (<45, 45-65 and >65 years) and per gender, using analysis of variance (ANOVA). The performance of the DAS28 and its components was explored in moderate to high and low DAS28 categories. Linear mixed model analysis was used to design the models best predicting ESR and the share of ESR. Results: ESR significantly increased with age, independent of other variables of disease activity. This increase was more pronounced in male than in female patients. Nevertheless, the share of ESR increased with age only in male patients with a low DAS28 (<3.2). If the DAS28 score was >3.2, age and gender did not have a significant effect on any components of the DAS28. C-reactive protein (CRP) and DAS28(CRP) were not influenced by age. Conclusions: A high DAS28 was found to perform equally in all age groups, in men and women, despite the elevating effect of age on ESR. In elderly men with low disease activity, remission rate could be underestimated by an elevated ESR.
引用
收藏
页码:1127 / 1131
页数:5
相关论文
共 23 条
[1]
DINANT GJ, 1991, BRIT J GEN PRACT, V41, P365
[2]
Fransen J, 2003, Arthritis Rheum, V49, pS214, DOI 10.1002/ art.11407
[3]
Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia [J].
Guralnik, JM ;
Eisenstaedt, RS ;
Ferrucci, L ;
Klein, HG ;
Woodman, RC .
BLOOD, 2004, 104 (08) :2263-2268
[4]
Assessing the impact of comorbidity in the older population [J].
Guralnik, JM .
ANNALS OF EPIDEMIOLOGY, 1996, 6 (05) :376-380
[5]
HENRY JB, 2001, CLIN DIAGNOSIS MANAG, P515
[6]
Kuiper S, 2001, J RHEUMATOL, V28, P1809
[7]
Makinodan T, 1980, Adv Immunol, V29, P287, DOI 10.1016/S0065-2776(08)60047-4
[8]
ACUTE PHASE REACTANTS IN THE ELDERLY [J].
MILMAN, N ;
GRAUDAL, N ;
ANDERSEN, HC .
CLINICA CHIMICA ACTA, 1988, 176 (01) :59-62
[9]
PETRIE A, 2005, MED STAT GLANCE, P20
[10]
MODIFIED DISEASE-ACTIVITY SCORES THAT INCLUDE 28-JOINT COUNTS - DEVELOPMENT AND VALIDATION IN A PROSPECTIVE LONGITUDINAL-STUDY OF PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
PREVOO, MLL ;
VANTHOF, MA ;
KUPER, HH ;
VANLEEUWEN, MA ;
VANDEPUTTE, LBA ;
VANRIEL, PLCM .
ARTHRITIS AND RHEUMATISM, 1995, 38 (01) :44-48